Mirjam Nägeli

1.2k total citations
30 papers, 534 citations indexed

About

Mirjam Nägeli is a scholar working on Dermatology, Molecular Biology and Oncology. According to data from OpenAlex, Mirjam Nägeli has authored 30 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Mirjam Nägeli's work include Cancer and Skin Lesions (9 papers), Nonmelanoma Skin Cancer Studies (9 papers) and Hedgehog Signaling Pathway Studies (8 papers). Mirjam Nägeli is often cited by papers focused on Cancer and Skin Lesions (9 papers), Nonmelanoma Skin Cancer Studies (9 papers) and Hedgehog Signaling Pathway Studies (8 papers). Mirjam Nägeli collaborates with scholars based in Switzerland, Austria and United States. Mirjam Nägeli's co-authors include Reinhard Dummer, Antonio Cozzio, Emmanuella Guenova, Wolfram Hoetzenecker, Ieva Saulīte, Lars E. French, Lea Felderer, Joanna Mangana, Peter Schmid‐Grendelmeier and Joachim C. Mertens and has published in prestigious journals such as Clinical Cancer Research, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Mirjam Nägeli

30 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirjam Nägeli Switzerland 11 159 157 153 152 112 30 534
Masami Kuniyoshi Japan 9 74 0.5× 51 0.3× 56 0.4× 239 1.6× 14 0.1× 13 428
Sara Mazzilli Italy 11 60 0.4× 228 1.5× 58 0.4× 137 0.9× 24 0.2× 42 413
Sara Grammatico Italy 11 246 1.5× 108 0.7× 167 1.1× 72 0.5× 32 0.3× 22 492
H. Makni Tunisia 14 57 0.4× 55 0.4× 82 0.5× 109 0.7× 15 0.1× 51 692
Mary Guckian United Kingdom 10 77 0.5× 49 0.3× 111 0.7× 79 0.5× 24 0.2× 13 465
Joseph Loane United Kingdom 11 184 1.2× 26 0.2× 145 0.9× 231 1.5× 7 0.1× 19 609
Omar Pacha United States 11 173 1.1× 83 0.5× 84 0.5× 39 0.3× 29 0.3× 29 490
Amira Elbendary Egypt 10 91 0.6× 91 0.6× 94 0.6× 73 0.5× 27 0.2× 39 392
Anne‐Marie Ros Sweden 11 45 0.3× 240 1.5× 56 0.4× 99 0.7× 7 0.1× 14 511
Leonardo Pescitelli Italy 12 31 0.2× 177 1.1× 45 0.3× 101 0.7× 8 0.1× 40 443

Countries citing papers authored by Mirjam Nägeli

Since Specialization
Citations

This map shows the geographic impact of Mirjam Nägeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Nägeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Nägeli more than expected).

Fields of papers citing papers by Mirjam Nägeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Nägeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Nägeli. The network helps show where Mirjam Nägeli may publish in the future.

Co-authorship network of co-authors of Mirjam Nägeli

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Nägeli. A scholar is included among the top collaborators of Mirjam Nägeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Nägeli. Mirjam Nägeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogelmann, Tobias, et al.. (2024). Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction. Journal of Clinical Apheresis. 39(3). e22128–e22128. 2 indexed citations
2.
Gómez, Julia M. Martínez, Patrick Turko, Egle Ramelyte, et al.. (2024). Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland. Cancers. 16(5). 854–854. 2 indexed citations
3.
Hafner, Jürg, Peter Schmid‐Grendelmeier, Thomas M. Kündig, et al.. (2023). Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life. Dermatology. 239(5). 811–817. 1 indexed citations
4.
Schmidt, Veronika, Stephan Traidl, Reihane Ziadlou, et al.. (2022). Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation. Allergy. 78(5). 1280–1291. 3 indexed citations
5.
Bader, Patrick R., et al.. (2022). Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report. Case Reports in Dermatology. 14(2). 203–209. 2 indexed citations
6.
Ramelyte, Egle, Mirjam Nägeli, Robert E. Hunger, et al.. (2022). Swiss Recommendations for Cutaneous Basal Cell Carcinoma. Dermatology. 239(1). 122–131. 6 indexed citations
7.
Ramelyte, Egle, et al.. (2021). 1089TiP Efficacy and tolerability of anti-PD1 antibody in combination with pulsed hedgehog inhibitor in advanced basal cell carcinoma. Annals of Oncology. 32. S901–S901. 4 indexed citations
8.
Chang, Yun‐Tsan, Christina Fassnacht, Florentia Dimitriou, et al.. (2021). Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome. OncoImmunology. 10(1). 1873530–1873530. 10 indexed citations
9.
Grünig, Hannes, Stephan Skawran, Mirjam Nägeli, Jivko Kamarachev, & Martin W. Huellner. (2021). Immunotherapy (Cemiplimab)-Induced Bullous Pemphigoid. Clinical Nuclear Medicine. 47(2). 185–186. 1 indexed citations
10.
Klein, Benjamin, et al.. (2021). Toxic epidermal necrolysis‐like acute cutaneous graft‐versus‐host disease in a stem cell recipient – a diagnostic dilemma. Journal of the European Academy of Dermatology and Venereology. 35(9). e585–e587. 2 indexed citations
11.
Ramelyte, Egle, Gaetana Restivo, Laurence Imhof, Mirjam Nägeli, & Reinhard Dummer. (2020). How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?. British Journal of Dermatology. 184(2). 359–361. 10 indexed citations
12.
Stampf, Susanne, Andreas Arnold, Antonio Cozzio, et al.. (2020). Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study). Dermatology. 237(6). 970–980. 11 indexed citations
13.
Dummer, Reinhard, Olivier Michielin, Mirjam Nägeli, et al.. (2018). Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma. ESMO Open. 3(5). e000388–e000388. 6 indexed citations
14.
Nägeli, Mirjam, et al.. (2016). Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome Cohort. Dermatology. 232(3). 285–292. 12 indexed citations
15.
Cheng, Phil F., Mirjam Nägeli, Mary E. Ziegler, et al.. (2016). An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel. British Journal of Dermatology. 175(5). 966–978. 8 indexed citations
16.
Guenova, Emmanuella, Tarun Mehra, Mirjam Nägeli, et al.. (2015). The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis. Dermatology. 231(2). 99–102. 10 indexed citations
17.
Otsuka, Atsushi, Phil F. Cheng, Mirjam Nägeli, et al.. (2015). Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma. Clinical Cancer Research. 21(6). 1289–1297. 88 indexed citations
18.
Hoetzenecker, Wolfram, Mirjam Nägeli, Ieva Saulīte, et al.. (2015). Adverse cutaneous drug eruptions: current understanding. Seminars in Immunopathology. 38(1). 75–86. 116 indexed citations
19.
Otsuka, Atsushi, et al.. (2015). 3349 Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma. European Journal of Cancer. 51. S685–S685. 1 indexed citations
20.
Dummer, Reinhard, et al.. (2014). Emerging drugs and combination strategies for basal cell carcinoma. Expert Opinion on Emerging Drugs. 19(3). 353–365. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masami Kuniyoshi Breakdown of academic impact, for papers by Sara Mazzilli Breakdown of academic impact, for papers by Sara Grammatico Breakdown of academic impact, for papers by H. Makni Breakdown of academic impact, for papers by Mary Guckian Breakdown of academic impact, for papers by Joseph Loane Breakdown of academic impact, for papers by Omar Pacha Breakdown of academic impact, for papers by Amira Elbendary Breakdown of academic impact, for papers by Anne‐Marie Ros Breakdown of academic impact, for papers by Leonardo Pescitelli
Rankless by CCL
2026